Principal Financial Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110M Sell
517,225
-8,808
-2% -$1.73M 0.05% 271
2026
Q1
$103M Sell
526,033
-5,253
-1% -$1.02M 0.06% 275
2025
Q4
$92.2M Sell
531,286
-3,184
-0.6% -$580K 0.05% 292
2025
Q3
$102M Sell
534,470
-27,101
-5% -$4.81M 0.05% 275
2025
Q2
$101M Sell
561,571
-6,785
-1% -$1.18M 0.05% 280
2025
Q1
$96.2M Buy
568,356
+24,884
+5% +$4.09M 0.05% 280
2024
Q4
$82M Buy
543,472
+104,495
+24% +$16.3M 0.04% 328
2024
Q3
$68.1M Buy
438,977
+68,844
+19% +$10.3M 0.04% 378
2024
Q2
$50.7M Buy
370,133
+2,436
+0.7% +$334K 0.03% 456
2024
Q1
$48.9M Buy
367,697
+112,784
+44% +$14.6M 0.03% 493
2023
Q4
$35.1M Buy
254,913
+112,582
+79% +$14.8M 0.02% 572
2023
Q3
$17.3M Sell
142,331
-1,403
-1% -$187K 0.01% 896
2023
Q2
$20.2M Sell
143,734
-12,285
-8% -$1.69M 0.01% 841
2023
Q1
$22.1M Sell
156,019
-647
-0.4% -$92.6K 0.02% 789
2022
Q4
$24.5M Sell
156,666
-10,695
-6% -$1.54M 0.02% 693
2022
Q3
$20.5M Buy
167,361
+15,172
+10% +$2M 0.02% 755
2022
Q2
$20.2M Sell
152,189
-32,103
-17% -$4.37M 0.02% 804
2022
Q1
$25.2M Sell
184,292
-9,701
-5% -$1.35M 0.02% 769
2021
Q4
$33.6M Sell
193,993
-9,016
-4% -$1.37M 0.02% 612
2021
Q3
$29.5M Buy
203,009
+20,940
+12% +$3.06M 0.02% 657
2021
Q2
$24M Buy
182,069
+5,968
+3% +$781K 0.02% 825
2021
Q1
$22.6M Sell
176,101
-8,891
-5% -$1.1M 0.02% 815
2020
Q4
$22M Sell
184,992
-15,733
-8% -$1.92M 0.02% 710
2020
Q3
$23M Sell
200,725
-10,378
-5% -$1.23M 0.02% 604
2020
Q2
$24.1M Buy
211,103
+1,440
+0.7% +$153K 0.02% 570
2020
Q1
$16.8M Sell
209,663
-2,413
-1% -$250K 0.02% 625
2019
Q4
$22.6M Sell
212,076
-6,692
-3% -$698K 0.02% 709
2019
Q3
$23.4M Sell
218,768
-2,678
-1% -$275K 0.02% 662
2019
Q2
$22.5M Sell
221,446
-22,307
-9% -$2.14M 0.02% 688
2019
Q1
$21.9M Sell
243,753
-3,079
-1% -$267K 0.02% 702
2018
Q4
$20.6M Sell
246,832
-62,406
-20% -$5.85M 0.02% 685
2018
Q3
$33.4M Sell
309,238
-29,499
-9% -$3.24M 0.03% 555
2018
Q2
$37.2M Sell
338,737
-97,380
-22% -$10.1M 0.03% 494
2018
Q1
$43.7M Buy
436,117
+81,936
+23% +$8.39M 0.04% 433
2017
Q4
$34.9M Sell
354,181
-72,594
-17% -$6.88M 0.03% 521
2017
Q3
$40M Buy
426,775
+106,529
+33% +$11.3M 0.04% 463
2017
Q2
$35.6M Buy
320,246
+44,740
+16% +$4.73M 0.04% 511
2017
Q1
$27.1M Buy
275,506
+31,464
+13% +$3M 0.03% 555
2016
Q4
$22.4M Buy
244,042
+9,350
+4% +$806K 0.03% 622
2016
Q3
$19.9M Buy
234,692
+1,108
+0.5% +$93.1K 0.03% 658
2016
Q2
$19M Buy
233,584
+125
+0.1% +$9.52K 0.03% 642
2016
Q1
$16.7M Buy
233,459
+613
+0.3% +$41.1K 0.02% 677
2015
Q4
$16.6M Buy
232,846
+740
+0.3% +$49.8K 0.02% 652
2015
Q3
$14.3M Buy
232,106
+5,169
+2% +$361K 0.02% 716
2015
Q2
$16.5M Sell
226,937
-923
-0.4% -$68.1K 0.02% 675
2015
Q1
$17.5M Buy
227,860
+24,838
+12% +$1.78M 0.03% 610
2014
Q4
$13.6M Buy
203,022
+26,894
+15% +$1.7M 0.02% 749
2014
Q3
$10.7M Sell
176,128
-224
-0.1% -$13.8K 0.02% 859
2014
Q2
$10.3M Sell
176,352
-9,853
-5% -$577K 0.02% 912
2014
Q1
$10.8M Sell
186,205
-3,352
-2% -$180K 0.02% 876
2013
Q4
$10.1M Sell
189,557
-8,167
-4% -$484K 0.02% 883
2013
Q3
$12.2M Sell
197,724
-14,085
-7% -$843K 0.03% 700
2013
Q2
$12.8M Buy
+211,809
New +$12.6M 0.03% 629

Other funds holding DGX

Principal Financial Group's DGX Position: Q2 2026 in Review

Principal Financial Group reduced its Quest Diagnostics (DGX) stake by 1.7% in Q2 2026, selling an estimated $1.73M and leaving 517,225 shares worth $110M. The position accounts for 0.05% of the portfolio, ranked #271.

Principal Financial Group first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Principal Financial Group held 517,225 shares of Quest Diagnostics worth $110M as of Q2 2026.
  • Principal Financial Group sold 8,808 Quest Diagnostics shares in Q2 2026, an estimated $1.73M.
  • Quest Diagnostics made up 0.05% of Principal Financial Group's portfolio in Q2 2026, its #271 holding.
  • Principal Financial Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.